Hidden Data on Obesity Drug Sends Amgen’s Market Value Plummeting by $12 Billion
In a stunning reversal of fortune, biotechnology giant Amgen Inc. suffered a staggering $12 billion loss in market capitalization after ...
Tag: Obesity
Viking Therapeutics’ Oral Obesity Drug Shows Promising 6.8% Weight Loss, Boosting Stock as Phase 1 Data Rolls Out
In the competitive arena of oral obesity treatments, Viking Therapeutics has made a strong showing with its obesity medication VK2735, ...
Boehringer Ingelheim Ends Development of Obesity Drug in Gubra Partnership
In a recent announcement, Boehringer Ingelheim has decided to end the development of one of its obesity drug candidates from ...
